Rapt Therapeutics, Inc. (RAPT)
58.02
0.00 (0.00%)
USD |
NASDAQ |
Mar 06, 16:00
Rapt Therapeutics Free Cash Flow : -86.66M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Penumbra, Inc. | 174.93M |
| Amicus Therapeutics, Inc. | 29.85M |
| Disc Medicine, Inc. | -181.33M |
| Amylyx Pharmaceuticals, Inc. | -123.48M |
| Johnson & Johnson | 19.70B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -12.46M |
| Cash from Investing (Quarterly) | 8.466M |
| Cash from Financing (Quarterly) | 0.036M |
| Free Cash Flow Per Share (Quarterly) | -0.462 |
| Free Cash Flow to Equity (Quarterly) | -11.89M |
| Free Cash Flow to Firm (Quarterly) | -12.46M |
| Free Cash Flow Yield | -1.89% |